Skip to main content

Table 1 Population demography and biomarker values

From: A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles

Paris-1

Paris-2

Lille-1

Lille-2

Montpellier-1

Montpellier-2

RSB

AD n = 118

Mean

SD

AD n = 41

Mean

SD

AD n = 118

Mean

SD

AD n = 73

Mean

SD

AD n = 129

Mean

SD

AD n = 142

Mean

SD

AD n = 213

Mean

SD

Age

73.6

8.8

Age

70.9

8.9

Age

68.3

9

Age

67

9.5

Age

69.7

8.8

Age

71.1

10.1

Age

66.3

8.7

Aβ42

440

189

Aβ42

594

238

Aβ42

338

162

Aβ42

603

245

Aβ42

505

224

Aβ42

654

256

Aβ42

420

224

Tau

598

295

Tau

543

279

Tau

608

336

Tau

778

364

Tau

611

327

Tau

702

727

Tau

666

407

p-tau

99

40.4

p-tau

86

34

p-tau

98.1

46.9

p-tau

101.5

41.2

p-tau

85.9

40.2

p-tau

86

37.7

p-tau

92.4

38.1

MMSE

19.4

5.6

MMSE

18.7

6.7

MMSE

18.1

6.5

MMSE

19.6

6.3

MMSE

21.9

5.5

MMSE

20.7

7.4

MMSE

19.0

6.1

Sex (%M)

47%

 

sex (%M)

65%

 

sex (%M)

37%

 

sex (%M)

47%

 

sex (%M)

47%

 

sex (%M)

49%

 

sex (%M)

50%

 

NAD n = 53

Mean

SD

NAD n = 68

Mean

SD

NAD n = 128

Mean

SD

NAD n = 51

Mean

SD

NAD n = 215

Mean

SD

NAD n = 147

Mean

SD

NAD n = 195

Mean

SD

Age

62.1

13.1

Age

67.4

11.1

Age

67.3

10.7

Age

64.6

10.7

Age

64.1

13.6

Age

63.4

13.6

Age

65.4

10.1

Aβ42

686

243

Aβ42

843

246

Aβ42

494

192

Aβ42

974

355

Aβ42

706

266

Aβ42

999

373

Aβ42

723

346

Tau

253

226

Tau

223

141

Tau

273

197

Tau

284

149

Tau

291

233

Tau

310

241

Tau

339

258

p-tau

48.6

23.1

p-tau

43.5

19.3

p-tau

52.6

28.7

p-tau

46.5

15.8

p-tau

44.8

23.7

p-tau

38.4

18.6

p-tau

49.3

25.8

MMSE

23

5.3

MMSE

23.6

4.9

MMSE

21.3

5.5

MMSE

21. 2

6

MMSE

20.7

7.1

MMSE

21.1

6.9

MMSE

21.0

6.1

Sex (%M)

53%

 

Sex (%M)

49%

 

sex (%M)

51%

 

sex (%M)

59%

 

sex (%M)

53%

 

sex (%M)

55%

 

sex (%M)

51%

 
  1. Mean and standard deviation of demographic data, CSF biomarker levels (Aβ42, tau, and p-tau) and Mini Mental Score (MMSE) for the patients with AD or NAD diagnosis in the different centers (Montpellier, Lille, Paris) in two independent cohorts that differed by their collection tubes (−1, −2) and in the three additional PLM centers: Rouen, Strasbourg, and Besançon (RSB).